Tempus is bringing data and AI to healthcare businesses through innovative technology solutions focused on clinical care and research products. With an integrated business model of sequencing patients ...

We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...

Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more than 50% of all oncologists practising in the US, Chicago-based Tempus will ...

Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM ...

We recently compiled a list of the 10 Firms Shine Amid Market Slump. In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. Ten companies ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. Optimistic sentiment continued to drive Wall Street on Thursday, with all major ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. Optimistic sentiment continued to drive Wall Street on Thursday, with all major ...